NINDS Advisory Council Agenda - May 28-29, 2015

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke

National Advisory Neurological Disorders and Stroke Council
193rd Meeting

May 28-29, 2015
Building 31, C Wing, 6th Floor, Conference Room 10
31 Center Drive
Bethesda, Maryland 20892
Closed Circuit Viewing Overflow on May 28 (Conference Rooms 7 and 9)


NIH Videocast Website

AGENDA

May 28, 2015

OPEN SESSION

8:00 a.m.
I.Call to Order and Opening Remarks - Dr. Walter Koroshetz

Chairperson
Acting Director, NINDS

8:05 a.m.
II.Report of the Director, Division of Extramural Research, NINDS - Dr. Robert Finkelstein

Executive Secretary
Director, Extramural Division, NINDS
A.Consideration of Minutes of January 29, 2015, Meeting
B.Confirmation of Dates for Future Council Meetings 
September 10-11, 2015           (Thursday and Friday)
February 4-5, 2016                  (Thursday and Friday)
May 26-27, 2016                      (Thursday and Friday)
September 15-16, 2016           (Thursday and Friday)
New Dates: February 9-10, 2017                 (Thursday and Friday)
May 18-19, 2017                      (Thursday and Friday)
September 7-8, 2017               (Thursday and Friday)

C.Other Items
Expedited Review Process
Extramural Announcements

8:15 a.m.
III.Report of the Acting Director, NINDS - Dr. Walter Koroshetz

9:15 a.m. BREAK

9:30 a.m.
IV.ASP Working Group Report - Dr. Amy Brooks-Kayal

Chief and Ponzio Family Chair in Pediatric Neurology
Children's Hospital Colorado
Professor of Pediatrics, Neurology and Pharmaceutical Sciences
University of Colorado

10:30 a.m.
V.Update from the Scientific Director of Intramural Research: Response to the Blue Ribbon Panel Report on the NINDS IRP - Dr. Alan Koretsky

Scientific Director, NINDS

11:30 a.m. LUNCH

12:45 p.m.
VI.Concept Clearance for Proposed Initiatives


Planning Grant for Morris K. Udall Center without Walls for Parkinson’s Disease Research (R34)

Dr. Beth-Anne Sieber
Program Director
Neurodegneration Cluster, NINDS

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)

Dr. Glen Nuckolls
Program Director
Neurogenetics Cluster, NINDS

1:45 p.m. BREAK
2:00 p.m.

CLOSED SESSION
This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

VII.Review of Conflict of Interest, Confidentiality, and Council Procedures Council Consideration of Pending Applications - Dr. Robert Finkelstein

5:00 p.m. **
ADJOURNMENT


May 29, 2015

CLOSED SESSION

8:00 a.m.
VIII.Consideration of Pending Applications (Continued) - Dr. Robert Finkelstein

10:00 a.m.
CLOSED SESSION (Continued)

This portion of the meeting is being closed to the public in accordance with the provisions set forth in section 552b(c) (6), Title 5 U.S. Code and Section 10 (d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

IX.Review of the Division of Intramural Research Board of Scientific Counselors’ Reports

Dr. Alan Koretsky

11:00 a.m. **
ADJOURNMENT

**This time is tentative